Hirsutismo y amenorrea en carcinoma adrenocortical oncocítico hormonalmente activo. Aportación de un caso y revisión de la literatura

Bovio, 2006, Prevalence of adrenal incidentaloma in a contemporary computerized tomography series, J Endocrinol Invest, 29, 298, 10.1007/BF03344099 Abiven, 2006, Clinical and biological features in the prognosis of adrenocortical cancer: Poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients, J Clin Endocrinol Metab, 91, 2650, 10.1210/jc.2005-2730 Sturgeon, 2006, Riskassessment in 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy, J Am Coll Surg, 202, 423, 10.1016/j.jamcollsurg.2005.11.005 Lughezzani, 2010, The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: A North American validation, Eur J Cancer, 46, 713, 10.1016/j.ejca.2009.12.007 Ayala-Ramirez, 2013, Adrenocortical carcinoma: Clinical outcomes and prognosis of 330 patients at a tertiary care center, Eur J Endocrinol, 169, 891, 10.1530/EJE-13-0519 Saunders, 2004, Laparoscopic adrenalectomy for malignant disease, Lancet, 5, 718, 10.1016/S1470-2045(04)01647-X Kebebew, 2002, Results of laparoscopic adrenalectomy for suspected and unsuspected malignant adrenal neoplasms, Arch Surg, 137, 948, 10.1001/archsurg.137.8.948 Mir, 2013, Comparative outcomes of laparoscopic and open adrenalectomy for adrenocortical carcinoma: Single, high-volume center experience, Ann Surg Oncol, 20, 1456, 10.1245/s10434-012-2760-1 Suzuki, 2006, Laparoscopic adrenalectomy for adrenal carcinoma and metastases, Curr Opin Urol, 16, 47, 10.1097/01.mou.0000193378.14694.9b Peppa, 2009, Adrenocortical carcinoma secreting cortisol, androgens and aldosterone: A case report, Cases Journal, 2, 8951, 10.4076/1757-1626-2-8951 Sabolch, 2011, Adjuvant and definitive radiotherapy for adrenocortical carcinoma, Int J Radiat Oncol Biol Phys, 80, 1477, 10.1016/j.ijrobp.2010.04.030 Reibetanz, 2012, German adrenocortical carcinoma registry. Surgical therapy results and follow-up treatment, Chirurg, 83, 528, 10.1007/s00104-011-2193-6 Markoe, 1991, Radiation therapy for adjunctive treatment of adrenal cortical carcinoma, Am J Clin Oncol, 14, 170, 10.1097/00000421-199104000-00015 Polat, 2009, Radiotherapy in adrenocortical carcinoma, Cancer, 115, 2816, 10.1002/cncr.24331 Cerquetti, 2008, Mitotane increases the radiotherapy inhibitory effect and induces G2-arrest in combined treatment on both H295R and SW13 adrenocortical celllines, Endocr Relat Cancer, 15, 623, 10.1677/erc.1.1315 Fassnacht, 2012, Combination chemotherapy in advanced adrenocortical carcinoma, N Engl J Med, 366, 2189, 10.1056/NEJMoa1200966 Bilimoria, 2008, Adrenocortical carcinoma in the United States: Treatment utilization and prognostic factors, Cancer, 113, 3130, 10.1002/cncr.23886 Else, 2014, Adjuvant therapies and patient and tumor characteristic sassociated with survival of adult patients with adrenocortical carcinoma, J Clin Endocrinol Metab, 99, 455, 10.1210/jc.2013-2856 Gonzalez, 2007, Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma, Surgery, 142, 867, 10.1016/j.surg.2007.09.006 Haak, 1994, Optimal treatment of adrenocortical carcinoma with mitotane: Results in a consecutive series of 96 patients, Br J Cancer, 69, 947, 10.1038/bjc.1994.183 Kendrick, 2001, Adrenocortical carcinoma: Surgical progressor status quo?, Arch Surg, 136, 543, 10.1001/archsurg.136.5.543 Habra, 2013, A retrospective cohort analysis of the efficacy of adjuvant radiotherapy after primary surgical resection in patients with adrenocortical carcinoma, J Clin Endocrinol Metab, 98, 192, 10.1210/jc.2012-2367 Sabolch, 2015, Adjuvant radiation therapy improves local control after surgical resection in patients with localized adrenocortical carcinoma, Int J Radiat Oncol Biol Phys, 92, 252, 10.1016/j.ijrobp.2015.01.007 Mayo-Smith, 2004, Adrenal neoplasms: CT-guided radiofrequency ablation preliminary results, Radiology, 23, 225, 10.1148/radiol.2311031007 Soga, 2009, A twelve-year experience with adrenal cortical carcinoma in a single institution: Long-term survival after surgical treatment and transcatheter arterial embolization, Urol Int, 82, 222, 10.1159/000200804 Mihai, 2012, Outcome of operation in patients with adrenocortical cancer invading the inferior vena cava. European Society of Endocrine Surgeons (ESES) survey, Langenbecks Arch Surg, 397, 225, 10.1007/s00423-011-0876-6 Aspinall, 2009, How is adrenocortical cancer being managed in the UK?, Ann R Coll Surg Engl, 91, 489, 10.1308/003588409X432284 Terzolo, 2007, Adjuvant mitotane treatment for adrenocortical carcinoma, N Engl J Med, 356, 2372, 10.1056/NEJMoa063360 Fassnacht, 2013, Update in adrenocortical carcinoma, J Clin Endocrin Metab, 98, 4551, 10.1210/jc.2013-3020 Ahlman, 2001, Cytotoxic treatment of adrenocortical carcinoma, World J Surg, 25, 927, 10.1007/s00268-001-0031-6 Berruti, 1998, Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma, Cancer, 83, 2194, 10.1002/(SICI)1097-0142(19981115)83:10<2194::AID-CNCR19>3.3.CO;2-V Khan, 2000, Streptozocin and o,p’DDD in the treatment of adrenocortical cancer patients: Long-term survival in its adjuvant use, Ann Oncol, 11, 1281, 10.1023/A:1008377915129 Sperone, 2010, Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: A multicenter phase ii study, Endocr Relat Cancer, 17, 445, 10.1677/ERC-09-0281 Berruti, 2011, Metronomic therapy concepts in the management of adrenocortical carcinoma, Horm Cancer, 2, 378, 10.1007/s12672-011-0087-1 Dackiw, 2001, Adrenal cortical carcinoma, World J Surg, 25, 914, 10.1007/s00268-001-0030-7 Mwandila, 2010, A case of a testosterone-secreting oncocytic adrenocortical carcinoma, N Z Med J, 123, 80